Ligand Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$893.99 | $961.26 | 17.45% | 8 | $96.07B |
| EBS | Emergent BioSolutions | Outperform |
16
|
$1.86 | $5.00 | 168.82% | 0 | $176.93M |